Awarded to
- Awarded value
- €11,902,014 47% under the estimate of €22,388,681
- Award date
- Record with this buyer
- 1 first contract from this buyer in the register
- Back on the market
- Jul 2027 How we know
When this contract comes back
estimated from the stated durationThis contract runs about 12 months, so it is back on the market around July 2027.
Every contract expiring, on the radarDescription
Przetarg uzupełniający na dostawę produktów leczniczych stosowanych w programach lekowych i chemioterapii ZP/PN/06/01/2026
jedna pozycja asortymentowa; dwie pozycje asortymentow; dwie pozycje asortymentowe; trzy pozycje asortymentowe; cztery pozycje asortymentowe
142 lots
- Lot 1
- Abirateron estimated €62,156 · 12 months
- Lot 2
- Acidum Levofolinicum estimated €18,526 · 12 months
- Lot 3
- Aflibercept estimated €3,795 · 12 months
- Lot 4
- Aprepitant estimated €78 · 12 months
- Lot 5
- Axitinib estimated €829 · 12 months
- Lot 6
- Bevacizumabum estimated €235,829 · 12 months
- Lot 7
- Bicalutamidum estimated €2,368 · 12 months
- Lot 8
- Bleomycinum estimated €2,025 · 12 months
- How tenders are scored
- Cena: 100 percent
Show 134 more lots
- Lot 9
- Cabazitaxelum estimated €26,308 · 12 months
- Lot 10
- Capecitabinum estimated €18,827 · 12 months
- Lot 11
- Carboplatinum estimated €13,398 · 12 months
- Lot 12
- Cetuximab estimated €333,293 · 12 months
- Lot 13
- Chlorambucilum estimated €93 · 12 months
- Lot 14
- Cisplatinum estimated €5,302 · 12 months
- Lot 15
- Cyclophosphamidum I estimated €1,136 · 12 months
- Lot 16
- Cyclophosphamidum II estimated €698 · 12 months
- Lot 17
- Cyclophosphamidum III estimated €263 · 12 months
- Lot 18
- Dacarbazinum estimated €1,567 · 12 months
- Lot 19
- Darbepoetinum alfa estimated €113,919 · 12 months
- Lot 20
- Denosumab estimated €5,719 · 12 months
- Lot 21
- Dexamethasone sodium phosphate estimated €18 · 12 months
- Lot 22
- Docetaxelum estimated €12,534 · 12 months
- Lot 23
- Doxorubicinum estimated €4,142 · 12 months
- Lot 24
- Doxorubicinum liposomalna pegylowana estimated €12,751 · 12 months
- Lot 25
- Doxorubicinum liposomalna estimated €7,849 · 12 months
- Lot 26
- Epirubicinum estimated €2,703 · 12 months
- Lot 27
- Erlotinibum estimated €2,122 · 12 months
- Lot 28
- Etoposidum estimated €3,036 · 12 months
- Lot 29
- Everolimus estimated €33,053 · 12 months
- Lot 30
- Filgrastimum estimated €3,761 · 12 months
- Lot 31
- Fluorouracilum estimated €10,524 · 12 months
- Lot 32
- Fulvestrantum estimated €27,463 · 12 months
- Lot 33
- Gefitynibum estimated €1,175 · 12 months
- Lot 34
- Gemcitabinum estimated €11,204 · 12 months
- Lot 35
- Hydroxycarbamidum estimated €104 · 12 months
- Lot 36
- Ifosfamidum estimated €1,447 · 12 months
- Lot 37
- Imatinibum estimated €5,334 · 12 months
- Lot 38
- Irinotecanum estimated €13,599 · 12 months
- Lot 39
- Lanreotidum estimated €12,546 · 12 months
- Lot 40
- Lapatinib estimated €3,904 · 12 months
- Lot 41
- Melphalanum estimated €131 · 12 months
- Lot 42
- Mesnum estimated €533 · 12 months
- Lot 43
- Methotrexatum estimated €1,028 · 12 months
- Lot 44
- Netupitantum+ Palonosetroni hydrochliridum estimated €5,014 · 12 months
- Lot 45
- Octreotidum estimated €26,442 · 12 months
- Lot 46
- Ondansetronum I estimated €3,396 · 12 months
- Lot 47
- Ondansetronum II estimated €42 · 12 months
- Lot 48
- Oxaliplatinum estimated €7,378 · 12 months
- Lot 49
- Paclitaxelum estimated €19,744 · 12 months
- Lot 50
- Paclitaxel albuminatum estimated €7,597 · 12 months
- Lot 51
- Panitumumab estimated €191,170 · 12 months
- Lot 52
- Pazopanib estimated €35,139 · 12 months
- Lot 53
- Pegfilgrastim estimated €109,688 · 12 months
- Lot 54
- Pemetrexed estimated €13,985 · 12 months
- Lot 55
- Rasburicasum estimated €829 · 12 months
- Lot 56
- Regorafenib estimated €128,664 · 12 months
- Lot 57
- Rituximab estimated €7,413 · 12 months
- Lot 58
- Sorafenib estimated €2,357 · 12 months
- Lot 59
- Sunitinib estimated €18,804 · 12 months
- Lot 60
- Temozolomidum estimated €2,664 · 12 months
- Lot 61
- Temsirolimus estimated €3,288 · 12 months
- Lot 62
- Topotecanum I estimated €4,329 · 12 months
- Lot 63
- Topotecanum II estimated €2,416 · 12 months
- Lot 64
- Trabectedinum estimated €4,250 · 12 months
- Lot 65
- Trastuzumab estimated €175,438 · 12 months
- Lot 66
- Vincristinum estimated €244 · 12 months
- Lot 67
- Vinorelbinum I estimated €653 · 12 months
- Lot 68
- Vinorelbinum II estimated €53,223 · 12 months
- Lot 69
- Abemaciclibum estimated €119,325 · 12 months
- Lot 70
- Afatinib estimated €19,195 · 12 months
- Lot 71
- Alectinibum estimated €162,283 · 12 months
- Lot 72
- Alpelisib estimated €45,703 · 12 months
- Lot 73
- Apalutamide estimated €449,054 · 12 months
- Lot 74
- Atezolizumab estimated €100,261 · 12 months
- Lot 75
- Avelumab estimated €144,736 · 12 months
- Lot 76
- Binimetinib estimated €63,386 · 12 months
- Lot 77
- Cabozantinib estimated €101,796 · 12 months
- Lot 78
- Capivasertibum estimated €413,092 · 12 months
- Lot 79
- Cemiplimab estimated €111,255 · 12 months
- Lot 80
- Cobimetynib estimated €19,587 · 12 months
- Lot 81
- Crizotinib estimated €20,858 · 12 months
- Lot 82
- Dabrafenib estimated €137,155 · 12 months
- Lot 83
- Darolutamide estimated €639,113 · 12 months
- Lot 84
- Dostrarlimab estimated €157,832 · 12 months
- Lot 85
- Durvalumab estimated €264,274 · 12 months
- Lot 86
- Encorafenib estimated €92,629 · 12 months
- Lot 87
- Enfortumab Vedotin estimated €123,053 · 12 months
- Lot 88
- Enzalutamid estimated €651,122 · 12 months
- Lot 89
- Erdafitinib estimated €493,842 · 12 months
- Lot 90
- Fruquintinib estimated €193,808 · 12 months
- Lot 91
- Infliximabum estimated €1,096,897 · 12 months
- Lot 92
- Ipilimumab estimated €497,487 · 12 months
- Lot 93
- Lorlatinib estimated €160,023 · 12 months
- Lot 94
- Mirvetuximabum soravtansinum estimated €76,468 · 12 months
- Lot 95
- Nintedanib (B.6.) estimated €44,176 · 12 months
- Lot 96
- Niraparib estimated €195,404 · 12 months
- Lot 97
- Nivolumab estimated €1,096,897 · 12 months
- Lot 98
- Niwolumab + Relatlimab estimated €409,744 · 12 months
- Lot 99
- Olaparib estimated €457,198 · 12 months
- Lot 100
- Osimertinib estimated €225,252 · 12 months
- Lot 101
- Palbociclibum estimated €52,102 · 12 months
- Lot 102
- Pembrolizumab estimated €6,129,732 · 12 months
- Lot 103
- Pertuzumabum estimated €417,158 · 12 months
- Lot 104
- Ramucirumab estimated €63,180 · 12 months
- Lot 105
- Ribociclibum estimated €546,216 · 12 months
- Lot 106
- Rucaparibum estimated €162,944 · 12 months
- Lot 107
- Sacituzumab govitecan estimated €32,266 · 12 months
- Lot 108
- Sotorasibum estimated €39,172 · 12 months
- Lot 109
- Talazoparib estimated €27,234 · 12 months
- Lot 110
- Trametynib estimated €129,804 · 12 months
- Lot 111
- Trastuzumab estimated €73,812 · 12 months
- Lot 112
- Trastuzumab derukstekan estimated €1,018,759 · 12 months
- Lot 113
- Trastuzumab emtansine estimated €696,726 · 12 months
- Lot 114
- Trastuzumabum + Pertuzumabum estimated €115,877 · 12 months
- Lot 115
- Tremelimumab estimated €37,217 · 12 months
- Lot 116
- Trifluridinum + Tipiracilum estimated €167,098 · 12 months
- Lot 117
- Tucatinibum estimated €31,624 · 12 months
- Lot 118
- Vemurafenib estimated €6,132 · 12 months
- Lot 119
- Dimethylis fumaras estimated €94,873 · 12 months
- Lot 120
- Glatirameri acetas estimated €31,731 · 12 months
- Lot 121
- Interferon β-1a I estimated €14,164 · 12 months
- Lot 122
- Interferon β-1a II estimated €7,260 · 12 months
- Lot 123
- Interferon β-1b estimated €13,744 · 12 months
- Lot 124
- Ocrelizumab estimated €323,490 · 12 months
- Lot 125
- Ofatumumab estimated €681,650 · 12 months
- Lot 126
- Ozanimod estimated €41,148 · 12 months
- Lot 127
- Peginterferon β-1a estimated €12,946 · 12 months
- Lot 128
- Cinacalcetum estimated €24,027 · 12 months
- Lot 129
- Palivizumab estimated €47,931 · 12 months
- Lot 130
- Benralizumab estimated €78,661 · 12 months
- Lot 131
- Nintedanib (B.87.) estimated €259,137 · 12 months
- Lot 132
- Pirfenidone estimated €7,313 · 12 months
- Lot 133
- Tezepelumabum estimated €78,661 · 12 months
- Lot 134
- Dimethyl sulfoxide estimated €1,825 · 12 months
- Lot 135
- Hyaluronidase estimated €678 · 12 months
- Lot 136
- Lomustine estimated €1,226 · 12 months
- Lot 137
- Procarbazine estimated €1,663 · 12 months
- Lot 138
- Etoposide estimated €2,710 · 12 months
- Lot 139
- Mitomycinum estimated €2,082 · 12 months
- Lot 140
- Mitoxantronum estimated €388 · 12 months
- Lot 141
- Topotecanum estimated €277 · 12 months
- Lot 142
- Vinblastin estimated €292 · 12 months
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago
What this buyer has paid before
Based on 106 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €11.9M
- Estimated value
- €22.4M
- Median award
- €111,294
- Middle half of past awards
- €38,183 to €765,438
The award is larger than three in four past awards.
Most recent awards
- Medical materials - Supply of urological medical devices, for Paediatric Surgery, biopsy needles, drainage accessories and products for the Otorhinolaryngology Department €54,830
- Produkty farmaceutyczne - Przetarg uzupełniający na dostawę do WCSKJ produktów leczniczych stosowanych w programach lekowych i chemioterapii €3,197,982
- Medical materials - Supply of medical products for the WCSKJ wards and the Parenteral Nutrition Unit €41,916
- Materiały medyczne - Dzierżawa wyposażania oraz dostawa odczynników i materiałów zużywalnych niezbędnych do wykonywania badań w Dziale Diagnostyki Laboratoryjnej (LDDL): Laboratorium Analityczne (LA) €1,497,242
- Materiały medyczne - Dostawa wyrobów medycznych specjalistycznych na potrzeby Pracowni Badań i Zabiegów Naczyniowych €1,302,959
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileWojewódzkie Centrum Szpitalne Kotliny Jeleniogórskiej
- notices in the register
- 342
- awards
- 153
- awarded in total
- €4.5B
Who wins its contracts
Many suppliers- different companies won its awards
- 106
- of the awards went to the three most frequent winners
- 13%
- of its calls state an estimated value
- 0%
Based on 131 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.4
- of those lots received a single tender
- 75%
- of the awards went to companies based in another country
- 1%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
- FARMACOL-LOGISTYKA Sp. z o.o.
- Perceptus Sp. z o.o.
- Medima Sp. z o.o.; BTL Polska Sp. z o.o.; Meden-Inmed Sp. z o.o.
12 open tenders right now
- Medical materials - Supply of specialist medical devices for the Neurosurgery Ward, General and Oncological Surgery Ward, gloves for the Cytostatic Drug Unit and gowns for the Operating Theatre ZP/PN/57/08/2026 1 day left
- Medical devices - Lease of equipment and supply of reagents and consumables for acid-base balance testing in the Operating Theatre 6 days left
- Medical materials - Supply of specialist medical devices for the Neurosurgery Ward, General and Oncological Surgery Ward, gloves for the Cytostatic Drug Unit and gowns for the Operating Theatre ZP/PN/57/08/2026 9 days left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,191
- median open notice
- €316,024
Who wins in this market
Many suppliersPoland · Medical equipment & pharmaceuticals
- different companies won awards here
- 13,424
- of the awards went to the three most frequent winners
- 4%
- buyers awarded contracts here
- 1,462
Based on 23,003 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 63%
- of the awards went to companies based in another country
- 2%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
2
days left
€2,926,817
est. value
Awarded before
Never miss a tender like this
987 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.